| P2093 | author name string | Ling Zhang | |
| | Shougang Zhuang | |
| | Jianfeng Du | |
| | Ting Cun Zhao | |
| | Gang Jian Qin | |
| P2860 | cites work | Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis | Q35847709 |
| | HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway | Q35975931 |
| | Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts | Q36408024 |
| | Hypoxia inhibits cardiomyocyte proliferation in fetal rat hearts via upregulating TIMP-4 | Q36770762 |
| | SUMOylation and De-SUMOylation: wrestling with life's processes | Q37325310 |
| | SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells. | Q40343731 |
| | Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors | Q44449807 |
| | Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding | Q46870302 |
| | Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury | Q46990138 |
| | Three proteins define a class of human histone deacetylases related to yeast Hda1p | Q22009464 |
| | Class II histone deacetylases: versatile regulators | Q24300376 |
| | The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. | Q24535620 |
| | HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor | Q24554388 |
| | The many roles of histone deacetylases in development and physiology: implications for disease and therapy | Q24628821 |
| | Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice | Q24650710 |
| | A role for histone deacetylase activity in HDAC1-mediated transcriptional repression | Q24682567 |
| | New and emerging HDAC inhibitors for cancer treatment | Q27022413 |
| | Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. | Q27863703 |
| | Post-translational modification by SUMO. | Q27865254 |
| | A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p | Q28141771 |
| | Roles of histone acetyltransferases and deacetylases in gene regulation | Q28286019 |
| | Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility. | Q30497896 |
| | The clinical development of histone deacetylase inhibitors as targeted anticancer drugs | Q33829390 |
| | gp-91 mediates histone deacetylase inhibition-induced cardioprotection | Q33892798 |
| | Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition | Q33917016 |
| | Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy | Q33929939 |
| | HDAC4: mechanism of regulation and biological functions | Q34039987 |
| | Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart | Q34062678 |
| | Targeted histone deacetylase inhibition for cancer therapy | Q34307179 |
| | SUMO--a post-translational modification with therapeutic potential? | Q34400369 |
| | Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease | Q34763178 |
| | HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1. | Q34769978 |
| P433 | issue | 6 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 1321-1331 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury | |
| P478 | volume | 230 | |